Is suppression of apoptosis a new therapeutic target in sepsis?

Anaesthesia and Intensive Care

Volumn 41, Issue 2, 2013, Pages 175-183

  Harjai, M ^a   Bogra, J ^a   Kohli, M ^a   Pant, A B ^a,b  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

^b Indian Institute of Toxicological Research   (India)

Author keywords

Apoptosis; Critical illness; Endotoxaemia; Lymphocyte; Sepsis

Indexed keywords

CARBOXY VALYL ALANYL ASPARTYL (O METHYL); CASPASE INHIBITOR; CYTOCHROME C; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VX 166;

APOPTOSIS; CELL SURFACE; DRUG TARGETING; GENE OVEREXPRESSION; HUMAN; IMMUNOCOMPETENT CELL; INHIBITION KINETICS; MOLECULAR MECHANICS; NONHUMAN; PATHOPHYSIOLOGY; REVIEW; SEPSIS; SEPTIC SHOCK; SIGNAL TRANSDUCTION;

EID: 84876805640     PISSN: 0310057X     EISSN: 14480271     Source Type: Journal    
DOI: 10.1177/0310057x1304100207     Document Type: Review

References (74)

1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29: 1303-1310. (Pubitemid 32641789)
2. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med 2003; 348: 138-150. (Pubitemid 36056721)
3. Tsujimoto H, Ono S, Efron PA, Scumpia PO, Moldawer LL, Mochizuki H. Role of Toll-like receptors in the development of sepsis. Shock 2008; 29: 315-321. (Pubitemid 351271701)
4. Hotchkiss RS, Nicholson DW. Apoptosis and caspases regulate death and inflammation in sepsis. Nat Rev Immunol 2006; 6: 813-822. (Pubitemid 44631650)
5. Hotchkiss RS, Swanson PE, Freeman BD, Tinsley KW, Cobb JP, Matuschak GM et al. Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med 1999; 27: 1230-1251. (Pubitemid 29379358)
6. Weber SU, Schewe JC, Lehmann LE, Müller S, Book M, Klaschik S et al. Induction of Bim and Bid gene expression during accelerated apoptosis in severe sepsis. Crit Care 2008; 12:R128.
7. Wesche DE, Lomas-Neira JL, Perl M, Chung CS, Ayala A. Leukocyte apoptosis and its significance in sepsis and shock. J Leukoc Biol 2005; 78: 325-337. (Pubitemid 41061305)
8. Ayala A, Perl M, Venet F, Lomas-Neira J, Swan R, Chung CS. Apoptosis in sepsis: mechanisms, clinical impact and potential therapeutic targets. Curr Pharm Des 2008; 14: 1853-1859.
9. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26: 239-257.
10. Raff M. Cell suicide for beginners. Nature 1998; 396: 119-122. (Pubitemid 28523602)
11. Haslett C, Savill J. Why is apoptosis important to clinicians? BMJ 2001; 322: 1499-1500. (Pubitemid 32588341)
12. Hotchkiss RS, Osmon SB, Chang KC, Wagner TH, Coopersmith CM, Karl IE. Accelerated lymphocyte death in sepsis occurs by both the death receptor and mitochondrial pathways. J Immunol 2005; 174: 5110-5118.
13. Ayala A, Herdon CD, Lehman DL, DeMaso CM, Ayala CA, Chaudry IH. The induction of accelerated thymic programmed cell death during polymicrobial sepsis: control by cortico-steroids but not tumor necrosis factor. Shock 1995; 3: 259-267.
14. Roy S, Nicholson DW. Cross-talk in cell death signaling. J Exp Med 2000; 192:F21-25.
15. Adams JM. Ways of dying: multiple pathways to apoptosis. Genes Dev 2003; 17: 2481-2495. (Pubitemid 37271417)
16. Esposti MD. The roles of Bid. Apoptosis 2002; 7: 433-440.
17. Marsden VS, Strasser A. Control of apoptosis in the immune system: Bcl-2, BH3-only proteins and more. Annu Rev Immunol 2003; 21: 71-105. (Pubitemid 37174527)
18. Chung CS, Song GY , Lomas J, Simms HH, Chaudry IH, Ayala A. Inhibition of Fas/Fas ligand signaling improves septic survival: differential effects on macrophage apoptotic and functional capacity. J Leukoc Biol 2003; 74: 344-351. (Pubitemid 38040394)
19. Hotchkiss RS, Tinsley KW, Karl IE. Role of apoptotic cell death in sepsis. Scand J Infect Dis 2003; 35: 585-592. (Pubitemid 37336877)
20. Hotchkiss RS, Swanson PE, Freeman BD, Tinsley KW, Cobb JP, Matuschak GM et al. Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med 1999; 27: 1230-1251. (Pubitemid 29379358)
21. Hotchkiss RS, Swanson PE, Knudson CM, Chang KC, Cobb JP, Osborne DF et al. Overexpression of Bcl-2 in transgenic mice decreases apoptosis and improves survival in sepsis. J Immunol 1999; 162: 4148-4156. (Pubitemid 29314800)
22. Hotchkiss RS, Tinsley KW, Swanson PE, Schmieg RE Jr, Hui JJ , Chang KC et al. Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans. J Immunol 2001; 166: 6952-6963. (Pubitemid 32467243)
23. Le Tulzo Y, Pangault C, Gacouin A, Guilloux V, Tribut O, Amiot L et al. Early circulating lymphocyte apoptosis in human septic shock is associated with poor outcome. Shock 2002; 18: 487-494.
24. Efron PA, Tinsley K, Minnich DJ, Monterroso V, Wagner J, Lainee P et al. Increased lymphoid tissue apoptosis in baboons with bacteremic shock. Shock 2004; 21: 566-571.
25. Shi X, LeCapitaine NJ, Rudner XL, Ruan S, Shellito JE. Lymphocyte apoptosis in murine Pneumocystis pneumonia. Respir Res 2009; 10:57.
26. Taneja R, Parodo J, Jia SH, Kapus A, Rotstein OD, Marshall JC. Delayed neutrophil apoptosis in sepsis is associated with maintenance of mitochondrial transmembrane potential and reduced caspase-9 activity. Crit Care Med 2004; 32: 1460-1469. (Pubitemid 38925173)
27. Sookhai S, Wang JJ , McCourt M, Kirwan W, Bouchier-Hayes D, Redmond P. A novel therapeutic strategy for attenuating neutrophil-mediated lung injury in vivo. Ann Surg 2002; 235: 285-291. (Pubitemid 34111959)
28. Iwata A, Stevenson VM, Minard A, Tasch M, Tupper J, Lagasse E et al. Over-expression of Bcl-2 provides protection in septic mice by a trans effect. J Immunol 2003; 171: 3136-3141. (Pubitemid 37093537)
29. Hotchkiss RS, Tinsley KW, Swanson PE, Grayson MH, Osborne DF, Wagner TH et al. Depletion of dendritic cells, but not macrophages, in patients with sepsis. J Immunol 2002; 168: 2493-2500. (Pubitemid 34171855)
30. Husain KD, Coopersmith CM. Role of intestinal epithelial apoptosis in survival. Curr Opin Crit Care 2003; 9: 159-163. (Pubitemid 36408136)
31. Tang PS, Mura M, Seth R, Liu M. Acute lung injury and cell death: how many ways can cells die? Am J Physiol Lung Cell Mol Physiol 2008; 294:L632-641. (Pubitemid 351520095)
32. Serrao KL, Fortenberry JD, Owens ML, Harris FL, Brown LA. Neutrophils induce apoptosis of lung epithelial cells via release of soluble Fas ligand. Am J Physiol Lung Cell Mol Physiol 2001; 280:L298-305.
33. Matsuda N, Takano Y, Kageyama SI, Hatakeyama N, Shakunaga K, Kitajima I et al. Silencing of caspase-8 and caspase-3 by RNA interference prevents vascular endothelial cell injury in mice with endotoxic shock. Cardiovasc Res 2007; 76: 132-140. (Pubitemid 47362040)
34. Moraes TJ, Downey GP. Death of the septic monocyte: is more better? Crit Care 2006; 10:146.
35. Bantel H, Schulze-Osthoff K. Cell death in sepsis: a matter of how, when, and where. Crit Care 2009; 13:173.
36. Power C, Fanning N, Redmond HP. Cellular apoptosis and organ injury in sepsis: a review. Shock 2002; 18: 197-211.
37. Hotchkiss RS, Chang KC, Grayson MH, Tinsley KW, Dunne BS, Davis CG et al. Adoptive transfer of apoptotic splenocytes worsens survival, whereas adoptive transfer of necrotic splenocytes improves survival in sepsis. Proc Natl Acad Sci U S A 2003; 100: 6724-6729. (Pubitemid 36666647)
38. Bilbault P, Lavaux T, Lahlou A, Uring-Lambert B, Gaub MP, Ratomponirina C et al. Transient Bcl-2 gene down-expression in circulating mononuclear cells of severe sepsis patients who died despite appropriate intensive care. Intensive Care Med 2004; 30: 408-415. (Pubitemid 38375614)
39. Turrel-Davin F, Guignant C, Lepape A, Mougin B, Monneret G, Venet F. Upregulation of the pro-apoptotic genes BID and FAS in septic shock patients. Crit Care 2010; 14:R133.
40. Hotchkiss RS, Swanson PE, Knudson CM, Chang KC, Cobb JP, Osborne DF et al. Overexpression of Bcl-2 in transgenic mice decreases apoptosis and improves survival in sepsis. J Immunol 1999; 162: 4148-4156. (Pubitemid 29314800)
41. Wesche-Soldato DE, Chung CS, Lomas-Neira J, Doughty LA, Gregory SH, Ayala A. In vivo delivery of caspase-8 or Fas siRNA improves the survival of septic mice. Blood 2005; 106: 2295-2301. (Pubitemid 41510799)
42. Tinsley KW, Cheng SL, Buchman TG, Chang KC, Hui JJ , Swanson PE et al. Caspases -2, -3, -6, and -9, but not caspase-1, are activated in sepsis-induced thymocyte apoptosis. Shock 2000; 13: 1-7.
43. Hotchkiss RS, Tinsley KW, Swanson PE, Chang KC, Cobb JP, Buchman TG et al. Prevention of lymphocyte cell death in sepsis improves survival in mice. Proc Natl Acad Sci U S A 1999; 96: 14541-14546. (Pubitemid 30000686)
44. Lamkanfi M, Moreira LO, Makena P, Spierings DCJ, Boyd K, Murray PJ et al. Caspase-7 deficiency protects from endotoxininduced lymphocyte apoptosis and improves survival. Blood 2009; 113: 2742-2745.
45. Weber P, Wang P, Maddens S, Wang PS, Wu R, Miksa M et al. VX-166: a novel potent small molecule caspase inhibitor as a potential therapy for sepsis. Crit Care 2009; 13:R146.
46. Wagner TH, Drewry AM, Macmillan S, Dunne WM, Chang KC, Karl IE et al. Surviving sepsis: bcl-2 overexpression modulates splenocyte transcriptional responses in vivo. Am J Physiol Regul Integr Comp Physiol 2007; 292:R1751-R1759. (Pubitemid 46557808)
47. Peck-Palmer OM, Unsinger J, Chang KC, McDonough JS, Perlman H, McDunn JE et al. Modulation of the Bcl-2 family blocks sepsis-induced depletion of dendritic cells and macrophages. Shock 2009; 31: 359-366.
48. Stromberg PE, Woolsey CA, Clark AT, Clark JA, Turnbull IR, McConnell KW et al. CD4+ lymphocytes control gut epithelial apoptosis and mediate survival in sepsis. FASEB J 2009; 23: 1817-1825.
49. Hotchkiss RS, Chang KC, Swanson PE, Tinsley KW, Hui JJ , Klender P et al. Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte. Nat Immunol 2000; 1: 496-501.
50. Chung CS, Venet F, Chen Y, Jones LN, Wilson DC, Ayala CA et al. Deficiency of Bid protein reduces sepsis-induced apoptosis and inflammation, while improving septic survival. Shock 2010; 34: 150-161.
51. Wang HL, Akinci IO, Baker CM, Urich D, Bellmeyer A, Jain M et al. The intrinsic apoptotic pathway is required for lipopolysaccharide- induced lung endothelial cell death. J Immunol 2007; 179: 1834-1841.
52. Bommhardt U, Chang KC, Swanson PE, Wagner TH, Tinsley KW, Karl IE et al. Akt decreases lymphocyte apoptosis and improves survival in sepsis. J Immunol 2004; 172: 7583-7591. (Pubitemid 38747622)
53. Bernstein E, Caudy AA, Hammond SM, Hannon GJ . Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 2001; 409: 363-366. (Pubitemid 32151243)
54. Dykxhoorn DM, Palliser D, Lieberman J. The silent treatment: siRNAs as small molecule drugs. Gene Ther 2006; 13: 541-552.
55. Song E, Lee SK, Wang J, Ince N, Ouyang N, Min J et al. RNA interference targeting Fas protects mice from fulminant hepatitis. Nat Med 2003; 9: 347-351. (Pubitemid 36362792)
56. G eisbert TW, Hensley LE, Kagan E, Yu EZ, Geisbert JB, Daddario-DiCaprio K et al. Postexposure protection of guinea pigs against a lethal ebola virus challenge is conferred by RNA interference. J Infect Dis 2006; 193: 1650-1657. (Pubitemid 43839469)
57. Perl M, Chung CS, Perl U, Thakkar R, Lomas-Neira J, Ayala A. Therapeutic accessibility of caspase-mediated cell death as a key pathomechanism in indirect acute lung injury. Crit Care Med 2010; 38: 1179-1186.
58. Cauwels A, Janssen B, Waeytens A, Cuvelier C, Brouckaert P. Caspase inhibition causes hyperacute tumor necrosis factorinduced shock via oxidative stress and phospholipase A2. Nat Immunol 2003; 4: 387-393. (Pubitemid 36432323)
59. Caserta TM, Smith AN, Gultice AD, Reedy MA, Brown TL. Q-VD-OPh, a broad spectrum caspase inhibitor with potent antiapoptotic properties. Apoptosis 2003; 8: 345-352. (Pubitemid 36935206)
60. Chang KC, Unsinger J, Davis CG, Schwulst SJ, Muenzer JT, Strasser A et al. Multiple triggers of cell death in sepsis: death receptor and mitochondrial-mediated apoptosis. FASEB J 2007; 21: 708-719. (Pubitemid 46348247)
61. Papathanassoglou ED, Moynihan JA, McDermott MP, Ackerman MH. Expression of Fas (CD95) and Fas ligand on peripheral blood mononuclear cells in critical illness and association with multiorgan dysfunction severity and survival. Crit Care Med 2001; 29: 709-718. (Pubitemid 32299706)
62. Chung CS, Xu YX, Wang W, Chaudry IH, Ayala A. Is Fas ligand or endotoxin responsible for mucosal lymphocyte apoptosis in sepsis? Arch Surg 1998; 133: 1213-1220. (Pubitemid 28516273)
63. Willis SN, Fletcher JI, Kaufmann T, van Delft MF, Chen L, Czabotar PE et al. Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak. Science 2007; 315: 856-859.
64. Schwulst SJ, Muenzer JT, Peck-Palmer OM, Chang KC, Davis CG, McDonough JS et al. Bim siRNA decreases lymphocyte apoptosis and improves survival in sepsis. Shock 2008; 30: 127-134.
65. J udge AD, Bola G, Lee ACH, MacLachlan I. Design of noninflammatory synthetic siRNA mediating potent gene silencing in vivo. Mol Ther 2006; 13: 494-505. (Pubitemid 43257617)
66. Matsuda N, Yamamoto S, Takano KI, Kageyama SI, Kurobe Y, Yoshihara Y et al. Silencing of fas-associated death domain protects mice from septic lung inflammation and apoptosis. Am J Respir Crit Care Med 2009; 179: 806-815.
67. Matsuda N, Teramae H, Yamamoto S, Takano KI, Takano Y, Hattori Y. Increased death receptor pathway of apoptotic signaling in septic mouse aorta: effect of systemic delivery of FADD siRNA. Am J Physiol Heart Circ Physiol 2010; 298: H92-101.
68. Brahmamdam P, Watanabe E, Unsinger J, Chang KC, Schierding W, Hoekzema AS et al. Targeted delivery of siRNA to cell death proteins in sepsis. Shock 2009; 32: 131-139.
69. Nguyen T, Menocal EM, Harborth J, Fruehauf JH. RNAi therapeutics: an update on delivery. Curr Opin Mol Ther 2008; 10: 158-167. (Pubitemid 351498878)
70. Davis ME, Zuckerman JE, Choi CH, Seligson D, Tolcher A, Alabi CA et al. Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature 2010; 464: 1067-1070.
71. Weaver JG , Tarze A, Moffat TC, Lebras M, Deniaud A, Brenner C et al. Inhibition of adenine nucleotide translocator pore function and protection against apoptosis in vivo by an HIV protease inhibitor. J Clin Invest 2005; 115: 1828-1838. (Pubitemid 40979721)
72. Iwata A, de Claro RA, Morgan-Stevenson VL, Tupper JC, Schwartz BR, Liu L et al. Extracellular administration of BCL2 protein reduces apoptosis and improves survival in a murine model of sepsis. PLoS One 2011; 6:e14729.
73. Levy RJ, Deutschman CS. Cytochrome c oxidase dysfunction in sepsis. Crit Care Med 2007; 35:S468-475. (Pubitemid 47312181)
74. Piel DA, Deutschman CS, Levy RJ. Exogenous cytochrome C restores myocardial cytochrome oxidase activity into the late phase of sepsis. Shock 2008; 29: 612-616. (Pubitemid 351544082)